Cargando…
Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer
BACKGROUND: Recent approvals of gene therapies by the FDA and the EMA for treatment of inherited disorders have further opened the door for assessment of nucleic acid pharmaceuticals for clinical usage. Arising from the presence of damaged or inappropriate DNA, cancer is a condition particularly sui...
Autores principales: | McCrudden, Cian M., McBride, John W., McCaffrey, Joanne, McErlean, Emma M., Dunne, Nicholas J., Kett, Vicky L., Coulter, Jonathan A., Robson, Tracy, McCarthy, Helen O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982451/ https://www.ncbi.nlm.nih.gov/pubmed/29899810 http://dx.doi.org/10.1186/s12645-018-0040-x |
Ejemplares similares
-
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment
por: McCrudden, Cian M., et al.
Publicado: (2017) -
Current status of gene therapy for breast cancer: progress and challenges
por: McCrudden, Cian M, et al.
Publicado: (2014) -
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
por: Jena, Lynn N, et al.
Publicado: (2021) -
Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
por: Jena, Lynn, et al.
Publicado: (2019) -
Synthesis and Evaluation of a Thermoresponsive Degradable Chitosan-Grafted PNIPAAm Hydrogel as a “Smart” Gene Delivery System
por: Ziminska, Monika, et al.
Publicado: (2020)